Lloydspharmacy blames income fall on drop in funding and prescriptions

Lloydspharmacy’s parent company has blamed the funding cuts in England and a drop in prescription volume for a fall in its income in the UK.

Lloydspharmacy_patientoutside_620%20%284%29.jpg
Lloydspharmacy's parent company says category M clawback will “negatively influence” planning

Latest from News

More from Multiples